NCT01644968
Phase 1 Study of Anti-OX40 in Patients With Advanced Cancer
Conditions: Advanced Cancer
Sponsors: Providence Health & Services
Phase: I
Phase 1 Study of Anti-OX40 in Patients With Advanced Cancer
Conditions: Advanced Cancer
Sponsors: Providence Health & Services
Phase: I
Baminercept in Sjögren's Syndrome
Conditions: Sjögren's Syndrome
Sponsors: National Institute of Allergy and Infectious Diseases (NIAID)
Phase: II
A Study to Determine the Immunogenicity and Oral Tolerance to Keyhole Limpet Hemocyanin (KLH)
Conditions: Autoimmune Disorders
Sponsors: National Institute of Allergy and Infectious Diseases (NIAID)
Phase 0
mRNA-transfected Dendritic Cell Vaccination in High Risk Uveal Melanoma Patients
Conditions: Uveal Melanoma
Sponsors: Radboud University Nijmegen Medical Centre
Phase n/a
A Study of AMG 557 in Adults With Systemic Lupus Erythematosus
Conditions: Systemic Lupus Erythematosus
Sponsors: Amgen
Phase I
Vaccine Therapy in Treating Patients With Newly Diagnosed Glioblastoma Multiforme
Conditions: Brain and Central Nervous System Tumors
Sponsors: Duke University, National Institute of Neurological Disorders and Stroke
Phase II
Condition: Renal Transplant
Sponsors: Hoffman-La Roche Inc.
Phase: IV
Conditions: Rheumatoid Arthritis
Sponsors: Genentech
Phase II
Immune Dysregulation in Children and Adults With Asthma
Conditions: Asthma, Lung Diseases
Sponsors: National Heart, Lung, and Blood Institute (NHLBI)
Phase n/a
Conditions: Non-Hodgkin’s Lymphoma
Sponsors: Biogen Idec Inc
Phase n/a